Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Amprol
2. Amprolium
3. Amprolium Chloride
4. Amprolium Hydrochloride
5. Anticoccid
6. Chloride, Amprolium
7. Hydrochloride, Amprolium
8. Hydrochloride, No-socopharm
9. Nmaprol
10. No Socopharm Hydrochloride
11. No-socopharm Hydrochloride
12. Pyridinium, 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-2-methyl-, Chloride (1:1)
1. Amprolium
2. 121-25-5
3. Amprolium Chloride
4. Corid
5. Chebi:85265
6. 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-2-picolinium Chloride
7. 2-picolinium, 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-, Chloride
8. 71m75t660b
9. 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-2-methylpyridinium Chloride
10. Amprocidum
11. Amprol, Veterinary
12. Anticoccid
13. Amprolium [inn:ban]
14. Amprolium [inn-latin]
15. Amprolio [inn-spanish]
16. Chembl97350
17. 1-[(4-amino-2-propylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium Chloride
18. Nsc-755872
19. 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-2-methylpyridinium Chloride Monohydrochloride
20. 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-2-picolinium Chloride Monohydrochloride
21. Einecs 204-458-4
22. 1-((4-amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium Chloride
23. 1-([4-amino-2-propyl-5-pyrimidinyl]methyl)-2-methylpyridinium Chloride
24. Unii-71m75t660b
25. Amprovine (tn)
26. Ampisol
27. Amprolsol
28. Amprolium (usp/inn)
29. Amprolium [inn]
30. Amprolium [mi]
31. Amprolium [who-dd]
32. Schembl362893
33. Dtxsid10904505
34. Hy-b0937
35. Mfcd00078831
36. 5-[(2-methylpyridin-1-ium-1-yl)methyl]-2-propylpyrimidin-4-amine;chloride
37. Akos015895454
38. Pyridinium, 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-2-methyl-, Chloride
39. Ccg-213062
40. Nsc 755872
41. Pyridinium, 1-((4-amino-2-propyl-5-pyrimidinyl)methyl)-2-methyl-, Chloride (1:1)
42. Ac-13690
43. Db-025452
44. Ft-0659069
45. D02928
46. Q4748545
47. 1-([4-amino-2-propyl-5-pyrimidinyl]methyl)-2-methylpyridiniumchloride
48. 1-(4-amino-2-n-propyl-5-pyrimidinylmethyl)-2-methylpyridinium Chloride
| Molecular Weight | 278.78 g/mol |
|---|---|
| Molecular Formula | C14H19ClN4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 278.1298243 g/mol |
| Monoisotopic Mass | 278.1298243 g/mol |
| Topological Polar Surface Area | 55.7 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 246 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Coccidiostats
Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]VMF
VMF Number : 5529
Submission : 1995-01-25
Status : Active
Type : II
VMF Number : 6046
Submission : 2013-05-23
Status : Active
Type : II
VMF Number : 5780
Submission : 2003-08-27
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
Regulatory Info :
Registration Country : Canada
Brand Name : AMPROMED
Dosage Form : SOLUTION
Dosage Strength : 96MG/ML
Packaging : 3.08L
Approval Date :
Application Number : 2458004
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : AMPROLIUM SOLUTION
Dosage Form : SOLUTION
Dosage Strength : 9.6%/W/V
Packaging :
Approval Date :
Application Number : 2529726
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : AMPROL
Dosage Form : SOLUTION
Dosage Strength : 9.6%/W/V
Packaging : 3.8L
Approval Date :
Application Number : 140481
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : AMPROL FEED PREMIX
Dosage Form : DRUG PREMIX
Dosage Strength : 250G/Kg
Packaging : 25KG
Approval Date :
Application Number : 140503
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Netherlands
Brand Name : Amprole 200
Dosage Form : Water Soluble Powder
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Netherlands
Regulatory Info :
Registration Country : Egypt
Brand Name : Amproxin
Dosage Form : Powder
Dosage Strength : 20%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Regulatory Info :
Registration Country : Egypt
Brand Name : Amproxin-E
Dosage Form : Oral Solution
Dosage Strength : 240MG; 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Regulatory Info :
Registration Country : China
Amprolium; Sulfaquinoxaline; Vitamin A; Vitamin K 3
Brand Name : Ampro & Sql-350 Plus
Dosage Form : WSP / Premix
Dosage Strength : 20%; 15%
Packaging : 100GM,500GM,1000GM
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name : Ampro-300
Dosage Form : WSP / Premix
Dosage Strength : 30%
Packaging : 100GM,500GM,1000GM
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info :
Registration Country : Canada
Brand Name : COCCIAID
Dosage Form : SOLUTION
Dosage Strength : 96MG/ML
Packaging :
Approval Date :
Application Number : 2521040
Regulatory Info :
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Amprolium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amprolium, including repackagers and relabelers. The FDA regulates Amprolium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amprolium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amprolium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amprolium supplier is an individual or a company that provides Amprolium active pharmaceutical ingredient (API) or Amprolium finished formulations upon request. The Amprolium suppliers may include Amprolium API manufacturers, exporters, distributors and traders.
click here to find a list of Amprolium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amprolium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amprolium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amprolium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amprolium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amprolium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amprolium suppliers with NDC on PharmaCompass.
Amprolium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amprolium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amprolium GMP manufacturer or Amprolium GMP API supplier for your needs.
A Amprolium CoA (Certificate of Analysis) is a formal document that attests to Amprolium's compliance with Amprolium specifications and serves as a tool for batch-level quality control.
Amprolium CoA mostly includes findings from lab analyses of a specific batch. For each Amprolium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amprolium may be tested according to a variety of international standards, such as European Pharmacopoeia (Amprolium EP), Amprolium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amprolium USP).
LOOKING FOR A SUPPLIER?
